Elderly Patients with Migraine: An Open-Label Study on Prophylaxis Therapy with Levetiracetam

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 11, Iss. 1, 2011-03 ,pp. : 31-34

Bentham Science Publishers

Access to resources Recommend Favorite

Efficacy and Tolerability of Lacosamide in the Concomitant Treatment of 130 Patients Under 16 Years of Age with Refractory Epilepsy: A Prospective, Open-Label, Observational, Multicenter Study in Spain

By Casas-Fernández Carlos  

Drugs in R&D, Vol. 12, Iss. 4, 2012-12 ,pp. : 187-197

Adis International

Access to resources Recommend Favorite

Long-Term Effects of Rivastigmine Treatment on the Need for Psychotropic Medications in Nursing Home Patients with Alzheimer’s Disease: Results of a 52-Week Open-Label Study

By Edwards Keith  

Clinical Drug Investigation, Vol. 25, Iss. 8, 2005-01 ,pp. : 507-515

Adis International

Access to resources Recommend Favorite

Use of Recombinant Human Parathyroid Hormone(1-84) in Patients with Postmenopausal Osteoporosis: A Prospective, Open-Label, Single-Arm, Multicentre, Observational Cohort Study of the Effects of Treatment on Quality of Life and Pain - the PROPOSE Study

By Möricke Rüdiger  

Clinical Drug Investigation, Vol. 31, Iss. 2, 2011-02 ,pp. : 87-99

Adis International

Access to resources Recommend Favorite

Short-Term Efficacy and Safety of Leflunomide in the Treatment of Active Rheumatoid Arthritis in Everyday Clinical Use: Open-Label, Prospective Study

By Nguyen M.  

Clinical Drug Investigation, Vol. 24, Iss. 2, 2004-01 ,pp. : 103-112

Adis International

Access to resources Recommend Favorite